Showing 1 to 10 of 94 Clinical Trials
|
CLINICAL TRIAL Trial No ClinicalTrials.gov ID |
Principal Investigator
Coordinator |
||
|---|---|---|---|
|
Banque des cellules leucémique du Québec
banque cellules leucémique  Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
L'HOTEL-DIEU DE QUEBEC ET CRCEO
|
Acute Myeloid Leukemia |
Dr. Marc Lalancette Marie-Pierre Brochu 418-525-4444 poste 15768 |
|
Banque des cellules leucémique du Québec
banque cellules leucémique Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
HOPITAL DE L'ENFANT-JESUS
|
Acute Myeloid Leukemia |
Dr. Robert Delage Linda Vallée 418-649-0252 poste 66602 |
|
A Phase 2, Randomized, Double-blind, Placebo- and Active-comparator Controlled Clinical Study of Adjuvant V940 (mRNA-4157) Plus Pembrolizumab Versus Adjuvant Placebo Plus Pembrolizumab in Participants With High-risk Muscle-invasive Urothelial Carcinoma Post-radical Resection
V940-005 NCT06305767 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
HOPITAL DE L'ENFANT-JESUS
|
Bladder/urothelial |
Dr. Vincent Castonguay Marilyn Savard 418-525-4444 poste 67703 |
|
A Phase II Randomized Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer
BicaBCa NCT05327647 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
L'HOTEL-DIEU DE QUEBEC ET CRCEO
|
Bladder/urothelial |
Dr. Paul Toren Marilyn Savard 418-525-4444 poste 20414 |
|
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
BN001 NCT02179086 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
L'HOTEL-DIEU DE QUEBEC ET CRCEO
|
Brain |
Dr. Nathalie Lessard Josée Allard 418-525-4444 poste 16730 |
|
Phase III Randomized Double-blind Placebo-controlled Trial of Metformin for Cognitive Recovery and White Matter Growth in Paediatric Medulloblastoma Patients
Met Med Can NCT05230758 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
CHUL ET CENTRE MERE-ENFANT SOLEIL
|
Brain |
Dr. Valérie Larouche Panagiota Giannakouros 418-525-4444 poste 40121 |
|
A Phase III Trial of Stereotactic Radiosurgery Compared With Whole Brain Radiotherapy (WBRT) for 5-15 Brain Metastases
CE.7 NCT03550391 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
L'HOTEL-DIEU DE QUEBEC ET CRCEO
|
Brain |
Dr. Jean Archambault Josée Allard 418-525-4444 poste 16730 |
|
A Phase 3 Study of Selumetinib or Selumetinib in Combination With Vinblastine for Non-NF1, Non-TSC Patients With Recurrent or Progressive Low-Grade Gliomas (LGGs) Lacking BRAFV600E or IDH1 Mutations
ACNS1931 NCT04576117 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
CHUL ET CENTRE MERE-ENFANT SOLEIL
|
Brain |
Dr. Valérie Larouche Panagiota Giannakouros 418-525-4444 poste 40121 |
|
A Phase 2 Trial of Chemotherapy Followed by Response-Based Whole Ventricular &Amp; Spinal Canal Irradiation (WVSCI) for Patients With Localized Non-Germinomatous Central Nervous System Germ Cell Tumor
ACNS2021 NCT04684368 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
CHUL ET CENTRE MERE-ENFANT SOLEIL
|
Brain |
Dr. Bruno Michon Panagiota Giannakouros 418-525-4444 poste 40121 |
|
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer
MA.39 NCT03488693 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
L'HOTEL-DIEU DE QUEBEC ET CRCEO
|
Breast |
Dr. Valérie Théberge Josée Allard 418-525-4444 poste 16730 |
Groupe d'étude en oncologie du Québec